Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version).
出版信息
Chin J Cancer Res. 2019 Feb;31(1):1-28. doi: 10.21147/j.issn.1000-9604.2019.01.01.
Abstract
摘要
相似文献
1
Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):1-28. doi: 10.21147/j.issn.1000-9604.2019.01.01.
2
Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version).
Chin J Cancer Res. 2019 Apr;31(2):259-277. doi: 10.21147/j.issn.1000-9604.2019.02.02.
3
Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version).
Chin J Cancer Res. 2019 Apr;31(2):278-294. doi: 10.21147/j.issn.1000-9604.2019.02.03.
4
Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version).
Chin J Cancer Res. 2019 Apr;31(2):295-305. doi: 10.21147/j.issn.1000-9604.2019.02.04.
5
Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version).
Chin J Cancer Res. 2019 Oct;31(5):707-737. doi: 10.21147/j.issn.1000-9604.2019.05.01.
6
Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):67-83. doi: 10.21147/j.issn.1000-9604.2019.01.04.
7
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):117-134. doi: 10.21147/j.issn.1000-9604.2019.01.07.
8
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):84-98. doi: 10.21147/j.issn.1000-9604.2019.01.05.
9
Equivalence of Chinese and US-English versions of the SF-36 health survey.
Qual Life Res. 2003 Jun;12(4):449-57. doi: 10.1023/a:1023446110727.
10
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):99-116. doi: 10.21147/j.issn.1000-9604.2019.01.06.
引用本文的文献
1
LncRNA MIR99AHG serves as a diagnostic marker for early lung cancer and regulates cancer cell growth and metastasis via miR-194-5p.
Discov Oncol. 2025 Jun 10;16(1):1050. doi: 10.1007/s12672-025-02896-3.
2
Excessive lymph node dissection increases postoperative cardiovascular disease risk in non-small cell lung cancer patients.
Sci Rep. 2025 Feb 17;15(1):5698. doi: 10.1038/s41598-025-90052-w.
3
Optimizing lung cancer surgery in the elderly: sublobar resection versus lobectomy for early-stage non-small cell lung cancer patients aged 80 and above.
Discov Oncol. 2024 Oct 23;15(1):585. doi: 10.1007/s12672-024-01468-1.
4
Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China.
Clin Med Insights Oncol. 2024 May 31;18:11795549241257234. doi: 10.1177/11795549241257234. eCollection 2024.
5
Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors.
World J Gastroenterol. 2024 Mar 21;30(11):1533-1544. doi: 10.3748/wjg.v30.i11.1533.
6
GABPB1 plays a cancer-promoting role in non-small cell lung cancer.
Discov Oncol. 2024 Mar 11;15(1):72. doi: 10.1007/s12672-024-00914-4.
7
Effects of "Timing It Right" nursing on clinical outcome and psychological resilience for lung cancer patients undergoing radical thoracoscopic surgery.
Am J Transl Res. 2024 Jan 15;16(1):179-189. doi: 10.62347/LUMW7355. eCollection 2024.
8
Repeated pulmonary nodules as the primary symptom of familial hemophagocytic lymphohistiocytosis in adults: a case report and review.
J Int Med Res. 2023 Sep;51(9):3000605231199019. doi: 10.1177/03000605231199019.
9
Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.
Front Oncol. 2023 Mar 27;13:1117348. doi: 10.3389/fonc.2023.1117348. eCollection 2023.
10
Lung adenocarcinoma relapse with emerging EGFR mutation following complete response of small cell lung cancer warrants routine re-biopsy: A case report.
Front Oncol. 2022 Oct 26;12:1024655. doi: 10.3389/fonc.2022.1024655. eCollection 2022.
Zotero 插件